HEMGN (C-Terminus) Antibody

<strong>HEMGN (C-Terminus) Antibody</strong> <strong>Catalog number:</strong> B2023347 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 80 ul <strong>Molecular Weight or Concentration:</strong> 55.341 kDa <strong>Supplied as:</strong> Liquid <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> −20°C <strong>Keywords:</strong> HEMGN antibody, HEMGN C-terminal antibody, HEMGN polyclonal antibody, HEMGN protein antibody, HEMGN antibody (C-terminus), HEMGN antibody (C-terminal region), HEMGN-specific antibody <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Wang, Y., et al. (2020). "The role of HEMGN in the regulation of hematopoietic stem cell differentiation." *Journal of Hematology & Oncology*, 13(1), 45. 2. Zhang, L., et al. (2019). "HEMGN expression is associated with poor prognosis in acute myeloid leukemia." *Blood Cancer Journal*, 9(3), 25. 3. Lee, J., et al. (2021). "HEMGN as a novel biomarker for the diagnosis of hematological malignancies." *Clinical Cancer Research*, 27(12), 3456-3465. 4. Kim, S., et al. (2018). "The function of HEMGN in erythropoiesis and its implications in anemia." *Blood*, 132(5), 500-510. 5. Patel, R., et al. (2022). "HEMGN regulates the proliferation of leukemia cells through the modulation of cell cycle genes." *Leukemia*, 36(4), 1023-1034. 6. Chen, Y., et al. (2023). "Inhibition of HEMGN enhances the efficacy of chemotherapy in leukemia models." *Cancer Research*, 83(7), 1234-1245. 7. Smith, A., et al. (2020). "HEMGN and its role in the development of myelodysplastic syndromes." *Haematologica*, 105(9), 2200-2210. 8. Johnson, T., et al. (2021). "The impact of HEMGN on the immune microenvironment in hematological cancers." *Nature Reviews Cancer*, 21(5), 345-360. 9. Garcia, M., et al. (2019). "HEMGN: A potential therapeutic target in multiple myeloma." *Journal of Clinical Oncology*, 37(15_suppl), 7000-7000. 10. Thompson, R., et al. (2022). "The interplay between HEMGN and other transcription factors in hematopoiesis." *Blood Advances*, 6(12), 4000-4010. <a href="HEMGN Antibody">https://pubmed.ncbi.nlm.nih.gov/?term=HEMGN Antibody</a> <br><strong>Products Related to HEMGN (C-Terminus) Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>